Peter W Marks
20PUBLICATIONS
63CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (20)
Sort by Publication Date:
|Jun 16, 2023
Synergistic Strategies to Accelerate the Development of Function-Promoting Therapies: Lessons From Operation Warp Speed and Oncology Drug Development.Rosaly Correa-de Araujo, William J Evans, Roger A Fielding
|Jan 25, 2023
Biological therapies need definitive randomized controlled clinical trials.Robert M Califf, Peter W Marks
|Mar 18, 2022
Early administration of COVID-19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy.Artur Belov, Yin Huang, Carlos H Villa
|Dec 20, 2021
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.Jonathon W Senefeld, Patrick W Johnson, Katie L Kunze
|Aug 12, 2021
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors.Katie L Kunze, Patrick W Johnson, Noud van Helmond
|Apr 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma.Jonathon W Senefeld, Patrick W Johnson, Katie L Kunze
Pageof 4
Frequent Collaborators
4 joint publications
Rickey E Carter
4 joint publications
Jonathon W Senefeld
4 joint publications
Philippe R Bauer
4 joint publications
Arturo Casadevall
3 joint publications
Patrick W Johnson
3 joint publications
Katie L Kunze
3 joint publications
Noud van Helmond
3 joint publications
Michael A Golafshar
3 joint publications
Chad C Wiggins
3 joint publications
Katelyn A Bruno
